Molecular cloning, expression, and bioactivity of dove B lymphocyte stimulator (doBAFF)

Veterinary Immunology and Immunopathology

Volumn 128, Issue 4, 2009, Pages 374-380

  Lu, Wuguang ^a,b   Cao, Peng ^b   Cai, Xueting ^b   Yu, Jiemiao ^b   Hu, Chunping ^b   Cao, Meng ^b   Zhang, Shuangquan ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

Author keywords

B cells survival; Dove B lymphocyte stimulator; Fusion protein; SUMO

Indexed keywords

B CELL ACTIVATING FACTOR; HYBRID PROTEIN; PROTEINASE; SUMO PROTEIN; ULP1 ENZYME; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOVE; ESCHERICHIA COLI; GENE AMPLIFICATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANIMALS; B-CELL ACTIVATING FACTOR; BASE SEQUENCE; BLOTTING, WESTERN; BURSA OF FABRICIUS; CLONING, MOLECULAR; COLUMBIDAE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PHYLOGENY; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SPLEEN;

ESCHERICHIA COLI;

EID: 61349134750     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.11.026     Document Type: Article

References (22)

1. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., and Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. Exp. Med. 192 (2000) 1453-1466
2. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27 (2002) 19-26
3. Butt T.R., Edavettal S.C., Hall J.P., and Mattern M.R. SUMO fusion technology for difficult-to-express proteins. Protein Exp. Purif. 43 (2005) 1-9
4. Cao P., Mei J.J., Diao Z.Y., and Zhang S.Q. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli. J. Protein Exp. Purif. 41 (2005) 99-206
5. Dan W.B., Guan Z.B., Zhang C., Li B.C., Zhang J., and Zhang S.Q. Molecular cloning, in vitro expression and bioactivity of goose B-cell activating factor. J. Vet. Immunol. Immunopathol. 118 (2007) 113-120
6. De VitaF S., Quartuccio L., and Fabris M. Hepatitis C virus infection, mixed crioglobulinemia cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?. Autoimmun. Rev. (2008) (PMID: 18589005)
7. Gao H., Bian A., Zheng Y., Li R., Ji Q., Huang G., Hu D., Zhang L., Gong W., Hu Y., and He F. sBAFF mutants induce neutralizing antibodies against BAFF. FEBS Lett. 581 (2007) 581-586
8. Gilbert J.A., Kalled S.L., Moorhead J., Hess D.M., Rennert P., Li Z., Khan M.Z., and Banga J.P. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147 (2006) 4561-4568
9. Gordon N.C., Pan B., Hymowitz S.G., Yin J., Kelley R.F., Cochran A.G., Yan M., Dixit V.M., Fairbrother W.J., and Starovasnik M.A. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry 42 (2003) 5977-5983
10. Guan Z.B., Ye J.L., Dan W.B., Yao W.J., and Zhang S.Q. Cloning, expression and bioactivity of duck BAFF. Mol. Immunol. 44 (2007) 1471-1476
11. Kalled S.L., Ambrose C., and Hsu Y.M. The biochemistry and biology of BAFF APRIL and their receptors. J. Curr. Dir. Autoimmun. 8 (2005) 206-242
12. Kern C., Cornuel J.F., Billard C., Tang R., Rouillard D., Stenou V., Defrance T., Cymbalista A.F., Simonin P.Y., Feldblum S., and Kolb J.P. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103 (2004) 679-688
13. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G., Ross L., Delaney J., Wang L., Lacey D., Boyle W.J., and Hsu H. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3370-3375
14. Koskela K., Nieminen P., Kohonen P., Salminen H., and Lassila O. Chicken B-cell-activating factor: regulator of B-cell survival in the bursa of fabricius. Scand. Immunol. 59 (2004) 449-457
15. MacLennan I., and Vinuesa C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17 (2002) 235-238
16. Mak T.W., and Yeh W.C. Signaling for survival and apoptosis in the immune system. Arthritis Res. 4 (2002) 243-252
17. Malakhov M.P., Mattern M.R., Malakhova O.A., Drinker M., Weeks S.D., and Butt T.R. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J. Struct. Funct. Genomics 5 (2004) 75-86
18. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D., Li Y., Galperina O., Giri J., Roschke V., Nardelli B., Carrell J., Sosnovtseva S., Greenfield W., Ruben S.M., Olsen H.S., Fikes J., and Hilbert D.M. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285 (1999) 260-263
19. Pelekanou V., Kampa M., Kafousi M., Darivianaki K., Sanidas E., Tsiftsis D.D., Stathopoulos E.N., Tsapis A., and Castanas E. Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas. BMC Cancer 8 (2008) 76
20. Sakurai D., Kanno Y., Hase H., Kojima H., Okumura K., and Kobata T. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur. J. Immunol. 37 (2007) 110-118
21. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Wermer-Favre C., Zubler R.H., Browning J.L., and Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189 (1999) 1747-1756
22. So T., Lee S.W., and Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int. J. Hematol. 83 (2006) 1-11